Publication|Videos|November 14, 2023
Ashland Launches Viatel™ Ultrapure Bioresorbable Polymers for LAIIs
Author(s)Ashland
Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.
Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment.
Related Content
Trending on Pharmaceutical Technology
1
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5